This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
23 Aug 2019  |  South Asia, Middle East & North Africa  |  Market Outlook
Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020
Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020
In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transp...
$4,950.00 -
18 Dec 2015  |  Global  |  Technology Alert
Medical Imaging—Toward Deep-Rooted Cancer Cell Imaging - Medical and Diagnostic Imaging Technology
This issue profiles cancer cell imaging technologies.
$950.00 -
11 Dec 2015  |  Global  |  Technology Alert
Futuretech TechVision Opportunity Engine--Therapeutics Devices (Non-Drug) for Sleep Apnea
This issue profiles technology advances and trends for the treatment of sleep apnea.
$750.00 -
27 Nov 2015  |  Global  |  Technology Alert
Medical and Diagnostic Imaging Technology TechVision Opportunity Engine--Innovating toward Enhanced Medical Imaging Platforms
This edition profiles innovations aimed at producing enhanced medical imaging platforms.
$950.00 -
30 Oct 2015  |  Global  |  Technology Alert
Medical And Diagnostic Imaging Technology--Medical Imaging Leading the Way to Better Diagnosis
This alert profiles medical imaging technologies that enable better diagnosis.
$950.00 -
24 Jul 2015  |  Global  |  Technology Alert
Medical Device Technology Alert. Novel Blood Pumping Device to Aid Heart Failure Patients; Ultrasound Diagnostic Tool for Bone Strength Assessment; Wearable Maternal-Fetal Monitor to Improve Prenatal Health
This issue profiles a novel blood pumping device to aid heart failure patients, an ultrasound diagnostic tool for bone strength assessment, and a wearable maternal-fetal monitor to improve prenatal health.
$950.00 -
24 Jul 2015  |  Global  |  Technology Alert
Nanotech Alert. Development of a Triboelectric Nanogenerator; Biomechanical Energy Harvesting with Piezoelectric Nanogenerators; Chemotherapy Enabled by Nanoparticles Treats Cancer Stem-Like Cells
This issue profiles development of a triboelectric nanogenerator, biomechanical energy harvesting with piezoelectric nanogenerators, and chemotherapy enabled by nanoparticles treats cancer stem-like cells.
$250.00 -
24 Jul 2015  |  Global  |  Technology Alert
Genetic Technology Alert. High-Priced Hepatitis C Drug Results in Development of Generic Products; FDA-Approved Rapid Antigen Test for Ebola; Focused Antiviral Clinical Programs for Infectious Diseases
This issue profiles a high-priced hepatitis c drug that results in development of generic products, a rapid antigen test for Ebola, and focused antiviral clinical programs for infectious diseases.
$250.00 -
17 Jul 2015  |  Global  |  Technology Alert
Medical and Diagnostic Imaging Technology Alert. Imaging App for Ultrasound; Compatible Leads for MRI Systems; Innovative Contrast Agents for Preclinical Imaging
This issue profiles an imaging app for ultrasound, a compatible leads for MRI systems, and innovative contrast agents for preclinical imaging.
$950.00 -
17 Jul 2015  |  Global  |  Technology Alert
Genetic Technology Alert. Drug for Oculopharyngeal Muscular Dystrophy Treatment Receives Orphan Drug Designation; Non-Viral CFTR-Based Gene Therapy for Cystic Fibrosis Patients; Breast Cancer Diagnostic Test in Europe
This issue profiles a drug for oculopharyngeal muscular dystrophy treatment that receives orphan drug designation; non-viral CFTR-based gene therapy for cystic fibrosis patients, a breast cancer diagnostic test in Europe.
$250.00